Revance Therapeutics | RVNC - 市值



市值 更改 日
AbbVie USD 403.83B 5.2B 2025-12
ALKERMES USD 4.47B 146M 2026-03
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Cara Therapeutics USD 28M 11M 2024-12
Coherus Biosciences USD 183M 11M 2026-03
Eli Lilly USD 1.02T 293.84B 2025-12
J&J USD 500.24B 67.44B 2025-12
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
P&G USD 334.88B 24.74B 2025-12
Pacira USD 1.06B 94M 2025-12
Supernus Pharmaceuticals USD 2.85B 151M 2025-12